Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.4 |